+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Monkeypox Antibody Test Reagent Market by Test Type (Iga, Igg, Igm), Technology Platform (Clia, Elisa, Rapid Lateral Flow), End User, Sample Type, Product Format, Application, Sales Channel - Global Forecast 2025-2030- Product Image
Monkeypox Antibody Test Reagent Market by Test Type (Iga, Igg, Igm), Technology Platform (Clia, Elisa, Rapid Lateral Flow), End User, Sample Type, Product Format, Application, Sales Channel - Global Forecast 2025-2030- Product Image
New

Monkeypox Antibody Test Reagent Market by Test Type (Iga, Igg, Igm), Technology Platform (Clia, Elisa, Rapid Lateral Flow), End User, Sample Type, Product Format, Application, Sales Channel - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 198 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6125124
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The rise of monkeypox as a global health concern has underscored the critical need for reliable serological tools capable of detecting immune responses with high specificity and sensitivity. In recent years, advancements in immunoassay design have catalyzed the development of novel reagents tailored for measuring IgA, IgG, IgM, and total antibody responses to the monkeypox virus. These reagents serve as the foundation for diagnostic workflows and epidemiological studies, empowering laboratories and health agencies to track outbreaks, support vaccine evaluation, and strengthen public health interventions.

Moreover, the integration of automated platforms and streamlined workflows has accelerated turnaround times and improved reproducibility across diverse laboratory environments. As health systems globally adapt to the challenges of emerging pathogens, the strategic deployment of serological reagents has become an indispensable element of comprehensive diagnostic portfolios. This introduction provides a concise framework for understanding how antibody test reagents are shaping the broader response to monkeypox, setting the stage for an in-depth exploration of market dynamics, regulatory shifts, and innovation trajectories.

Revolutionary Diagnostic Innovations Are Reshaping the Monkeypox Antibody Reagent Landscape to Meet Escalating Demand for Rapid and Accurate Detection

Diagnostic innovation is undergoing a profound transformation as next-generation technologies converge to address the complexities of monkeypox serology. Automation platforms that leverage chemiluminescence immunoassay principles are achieving unprecedented throughput, while established enzyme-linked assays continue to evolve with enhanced detection chemistries. Rapid lateral flow devices now incorporate colloidal gold and fluorescent readouts, enabling decentralized testing strategies that bring reliable results closer to the point of care.

Simultaneously, integration with digital health ecosystems has created opportunities for real-time data capture and remote interpretation, reducing the burden on centralized laboratories. In parallel, regulatory agencies have expedited pathways for emergency use authorizations, encouraging continued investment in assay development and manufacturing scale-up. These shifts collectively signal a paradigm where agility, connectivity, and enhanced performance converge to redefine what is possible in antibody reagent testing for emerging infectious threats.

Evolving Tariff Policies in the United States Are Reshaping International Trade Dynamics for Monkeypox Antibody Reagents in 2025

Evolving tariff structures imposed by the United States on imported biochemical components and finished reagents are influencing global supply chains for monkeypox antibody test materials. Imported assay kits and bulk reagents incur levies that drive suppliers to reevaluate sourcing strategies and consider vertical integration of manufacturing processes. Domestic producers are positioned to benefit from incentives designed to reduce reliance on foreign imports, leading to potential shifts in capacity investments and long-term partnership models.

In response, international suppliers are exploring alternate distribution channels and adjusting pricing frameworks to mitigate cost pressures. Cross-border collaborations are gaining momentum as stakeholders seek to establish regional warehousing hubs that streamline logistics and ensure continuity of supply. Ultimately, the interplay between tariff policies and strategic sourcing decisions will shape the accessibility and affordability of critical serological reagents for public health laboratories and clinical diagnostics.

In-Depth Analysis of Diverse Segmentation Factors Uncover Strategic Opportunities in Monkeypox Antibody Testing Tools

A nuanced segmentation approach reveals distinct opportunities across test types, technology platforms, and end-user categories. Assay developers are tailoring protocols for immunoglobulin A, G and M isotypes as well as total antibody detection to address varied clinical objectives-from recent infection monitoring to retrospective serosurveys. Likewise, platforms spanning chemiluminescence immunoassays, enzyme-linked immunosorbent assays, and rapid lateral flow tests with colloidal gold or fluorescent labels are each finding unique applications based on performance needs and operational settings.

Laboratories in both public health and private sectors-from high-throughput diagnostic centers to academic research institutes-are diversifying their reagent portfolios to match sample matrices that range from plasma and serum to whole blood. Product formats extend from bulk reagents designed for automated systems to all-in-one kits that simplify workflow in decentralized environments. Application areas further differentiate offerings, as clinical diagnosis workflows in central labs and point-of-care sites interface with epidemiological surveillance efforts such as contact tracing studies and seroprevalence surveys, along with research initiatives and vaccine development programs. Sales channels from direct contracting-whether through government or private tenders-to national and regional distribution networks and online procurement platforms complete the segmentation landscape, illuminating pathways for targeted commercialization and adoption strategies.

Regional Market Dynamics Reveal Strategic Growth Platforms across the Americas, Europe Middle East Africa and Asia-Pacific

Regional dynamics are shaping the trajectory of monkeypox antibody reagent adoption, with each geography exhibiting distinctive drivers and constraints. In the Americas, robust public health infrastructure, coupled with strategic government procurement initiatives, accelerates deployment of cutting-edge immunoassays. Diagnostic laboratories across North America leverage collaborations with academic centers to validate novel test protocols, while supply chain networks in Latin America adapt to local regulatory environments through agile distribution models.

Europe, the Middle East and Africa present a mosaic of harmonized regulatory frameworks and emerging market potential. In Western Europe, synchronized authorization procedures facilitate multi-country reagent approvals, whereas public health laboratories in the Middle East are harnessing enhanced surveillance funding to expand serological testing. African nations, in partnership with international aid organizations, are implementing seroprevalence surveys that rely on robust reagent pipelines, driving demand for cost-effective, kit-based solutions.

Across Asia-Pacific, rapid industrialization and investment in biomanufacturing are enabling domestic production of antibody test reagents. Collaborative research hubs in East Asia refine fluorescent lateral flow technologies, while Southeast Asian health agencies incorporate serological assays into routine diagnostic algorithms. Australia and New Zealand’s centralized regulatory authorities further streamline market entry, fostering an environment where innovation and accessibility converge.

Corporate Strategies and Technological Leadership Define the Competitive Sphere of Monkeypox Antibody Reagent Manufacturers

Key players in the antibody reagent space are forging alliances and scaling production to meet evolving market needs. BioRad Laboratories, Euroimmun and Thermo Fisher Scientific have reinforced their global footprint through manufacturing expansions and licensing partnerships, ensuring reliable reagent availability. Concurrently, emerging biotechnology firms such as Quanterix and GenScript are advancing specialized assay chemistries and offering custom reagent services that cater to research institutions and vaccine developers.

Established diagnostics companies like Abbott and Beckman Coulter are integrating monkeypox serology capabilities into their automated immunoassay platforms, providing laboratories with seamless workflow upgrades. Niche reagent suppliers, including Meridian Life Science and Becton Dickinson, are differentiating through rapid lateral flow solutions optimized for field use. Collectively, these organizations are deploying strategic investments in R&D, collaborative validation studies, and regional distribution agreements, reinforcing their leadership in a rapidly evolving landscape.

Strategic Actions Empower Industry Leaders to Navigate Challenges and Capitalize on Emerging Opportunities in Monkeypox Testing

Industry leaders should prioritize investments in next-generation immunoassay platforms that deliver both high throughput and point-of-care flexibility, supporting diverse end-user needs from centralized laboratories to remote clinics. Strengthening vertical integration through in-house manufacturing of critical components can mitigate tariff impacts and enhance supply chain resilience. Collaborative engagements with regulatory authorities will facilitate accelerated approvals, while participation in global proficiency testing programs will underscore assay reliability.

Additionally, forging strategic partnerships with digital health providers can extend assay capabilities through remote data analytics and result interpretation, unlocking new service models. Tailored training programs for clinical and public health laboratory personnel will drive adoption and ensure standardized testing quality. Finally, expanding distribution networks to encompass both direct and regional channels-while optimizing online procurement portals-will strengthen market access and support scalable growth across multiple geographies.

Robust Research Methodology Ensures Reliable Insights into the Monkeypox Antibody Reagent Landscape through Rigorous Data Collection

This analysis is founded upon a rigorous research framework that combines extensive secondary research with targeted primary engagements. Peer-reviewed publications, regulatory filings, and public health agency reports provided foundational insights into assay performance benchmarks and evolving diagnostic guidelines. These were augmented by interviews with key opinion leaders, including laboratory directors, reagent manufacturing executives, and public health officials, to validate emerging trends and practical implementation considerations.

Data triangulation methods were employed to reconcile disparate information sources, ensuring the accuracy and integrity of the insights presented. A cross-functional expert panel reviewed preliminary findings, offering critical feedback that shaped the final analysis. Quality control protocols were systematically applied at each stage, from data collection and synthesis to content validation, resulting in a comprehensive and reliable perspective on the monkeypox antibody reagent ecosystem.

Synthesized Insights Highlight the Pivotal Role of Innovative Monkeypox Antibody Reagent Solutions in Strengthening Health Security

The convergence of advanced immunoassay technologies, strategic supply chain realignments, and dynamic regulatory environments is reshaping how practitioners approach monkeypox antibody testing. Innovative reagents across multiple test formats are enhancing diagnostic precision, while transformative shifts in trade policies and manufacturing capacities are diversifying sourcing strategies. Regional growth trajectories underscore the importance of localized solutions, and leading organizations are leveraging collaborative frameworks to stay ahead.

As health systems globally continue to adapt, the insights detailed in this executive summary will inform strategic planning, operational optimization, and product development initiatives. By synthesizing segmentation, regional, and competitive dynamics, stakeholders can make informed decisions that bolster preparedness, improve outbreak response capabilities, and support long-term public health resilience.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Test Type
    • Iga
    • Igg
    • Igm
    • Total Antibody
  • Technology Platform
    • Clia
    • Elisa
    • Rapid Lateral Flow
      • Colloidal Gold
      • Fluorescent
  • End User
    • Diagnostic Laboratory
    • Hospital
    • Public Health Laboratory
    • Research Institute
  • Sample Type
    • Plasma
    • Serum
    • Whole Blood
  • Product Format
    • Bulk Reagent
    • Kit
  • Application
    • Clinical Diagnosis
      • Central Lab
      • Point Of Care
    • Epidemiological Surveillance
      • Contact Tracing Studies
      • Seroprevalence Surveys
    • Research
    • Vaccine Development
  • Sales Channel
    • Direct Sales
      • Government Contracts
      • Private Contracts
    • Distributor
      • National Distributors
      • Regional Distributors
    • Online Sales
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report delves into recent significant developments and analyzes trends in each of the following companies:
  • Thermo Fisher Scientific Inc.
  • Roche Diagnostics International AG
  • Abbott Laboratories
  • QIAGEN N.V.
  • PerkinElmer, Inc.
  • Bio-Rad Laboratories, Inc.
  • bioMérieux SA
  • DiaSorin S.p.A.
  • Bio-Techne Corporation
  • Virion\Serion GmbH

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Increasing demand for high-throughput monkeypox antibody test reagents in centralized clinical laboratories
5.2. Expansion of authorized monkeypox serology kits under emergency use authorization in major markets
5.3. Implementation of next-generation immunoassay platforms for quantitative monkeypox antibody profiling in research settings
5.4. Rising partnerships between biotech firms and public health agencies to scale up monkeypox antibody test distribution networks
5.5. Development of lateral flow immunochromatographic assays for rapid point-of-care monkeypox antibody detection in outbreak zones
5.6. Integration of digital data reporting solutions into monkeypox antibody testing workflows to enhance epidemiological surveillance capabilities
5.7. Growing focus on cross-reactivity studies to improve specificity of monkeypox antibody reagents against other orthopoxviruses
5.8. Adoption of recombinant antigen technologies to boost sensitivity and batch consistency of monkeypox serological reagents
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Monkeypox Antibody Test Reagent Market, by Test Type
8.1. Introduction
8.2. Iga
8.3. Igg
8.4. Igm
8.5. Total Antibody
9. Monkeypox Antibody Test Reagent Market, by Technology Platform
9.1. Introduction
9.2. Clia
9.3. Elisa
9.4. Rapid Lateral Flow
9.4.1. Colloidal Gold
9.4.2. Fluorescent
10. Monkeypox Antibody Test Reagent Market, by End User
10.1. Introduction
10.2. Diagnostic Laboratory
10.3. Hospital
10.4. Public Health Laboratory
10.5. Research Institute
11. Monkeypox Antibody Test Reagent Market, by Sample Type
11.1. Introduction
11.2. Plasma
11.3. Serum
11.4. Whole Blood
12. Monkeypox Antibody Test Reagent Market, by Product Format
12.1. Introduction
12.2. Bulk Reagent
12.3. Kit
13. Monkeypox Antibody Test Reagent Market, by Application
13.1. Introduction
13.2. Clinical Diagnosis
13.2.1. Central Lab
13.2.2. Point of Care
13.3. Epidemiological Surveillance
13.3.1. Contact Tracing Studies
13.3.2. Seroprevalence Surveys
13.4. Research
13.5. Vaccine Development
14. Monkeypox Antibody Test Reagent Market, by Sales Channel
14.1. Introduction
14.2. Direct Sales
14.2.1. Government Contracts
14.2.2. Private Contracts
14.3. Distributor
14.3.1. National Distributors
14.3.2. Regional Distributors
14.4. Online Sales
15. Americas Monkeypox Antibody Test Reagent Market
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. Argentina
16. Europe, Middle East & Africa Monkeypox Antibody Test Reagent Market
16.1. Introduction
16.2. United Kingdom
16.3. Germany
16.4. France
16.5. Russia
16.6. Italy
16.7. Spain
16.8. United Arab Emirates
16.9. Saudi Arabia
16.10. South Africa
16.11. Denmark
16.12. Netherlands
16.13. Qatar
16.14. Finland
16.15. Sweden
16.16. Nigeria
16.17. Egypt
16.18. Turkey
16.19. Israel
16.20. Norway
16.21. Poland
16.22. Switzerland
17. Asia-Pacific Monkeypox Antibody Test Reagent Market
17.1. Introduction
17.2. China
17.3. India
17.4. Japan
17.5. Australia
17.6. South Korea
17.7. Indonesia
17.8. Thailand
17.9. Philippines
17.10. Malaysia
17.11. Singapore
17.12. Vietnam
17.13. Taiwan
18. Competitive Landscape
18.1. Market Share Analysis, 2024
18.2. FPNV Positioning Matrix, 2024
18.3. Competitive Analysis
18.3.1. Thermo Fisher Scientific Inc.
18.3.2. Roche Diagnostics International AG
18.3.3. Abbott Laboratories
18.3.4. QIAGEN N.V.
18.3.5. PerkinElmer, Inc.
18.3.6. Bio-Rad Laboratories, Inc.
18.3.7. BioMérieux SA
18.3.8. DiaSorin S.p.A.
18.3.9. Bio-Techne Corporation
18.3.10. Virion\Serion GmbH
19. ResearchAI
20. ResearchStatistics
21. ResearchContacts
22. ResearchArticles
23. Appendix
List of Figures
FIGURE 1. MONKEYPOX ANTIBODY TEST REAGENT MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TEST TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TEST TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TECHNOLOGY PLATFORM, 2024 VS 2030 (%)
FIGURE 8. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TECHNOLOGY PLATFORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY PRODUCT FORMAT, 2024 VS 2030 (%)
FIGURE 14. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY PRODUCT FORMAT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 16. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SALES CHANNEL, 2024 VS 2030 (%)
FIGURE 18. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SALES CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. MONKEYPOX ANTIBODY TEST REAGENT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. MONKEYPOX ANTIBODY TEST REAGENT MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 29. MONKEYPOX ANTIBODY TEST REAGENT MARKET: RESEARCHAI
FIGURE 30. MONKEYPOX ANTIBODY TEST REAGENT MARKET: RESEARCHSTATISTICS
FIGURE 31. MONKEYPOX ANTIBODY TEST REAGENT MARKET: RESEARCHCONTACTS
FIGURE 32. MONKEYPOX ANTIBODY TEST REAGENT MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. MONKEYPOX ANTIBODY TEST REAGENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY IGA, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY IGA, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY IGG, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY IGG, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY IGM, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY IGM, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TOTAL ANTIBODY, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TOTAL ANTIBODY, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY CLIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY CLIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY ELISA, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY ELISA, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY RAPID LATERAL FLOW, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY RAPID LATERAL FLOW, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY COLLOIDAL GOLD, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY COLLOIDAL GOLD, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY FLUORESCENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY FLUORESCENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY RAPID LATERAL FLOW, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY RAPID LATERAL FLOW, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY DIAGNOSTIC LABORATORY, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY DIAGNOSTIC LABORATORY, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY PUBLIC HEALTH LABORATORY, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY PUBLIC HEALTH LABORATORY, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY RESEARCH INSTITUTE, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY RESEARCH INSTITUTE, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY PLASMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY PLASMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SERUM, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SERUM, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY WHOLE BLOOD, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY WHOLE BLOOD, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY PRODUCT FORMAT, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY PRODUCT FORMAT, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY BULK REAGENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY BULK REAGENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY KIT, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY KIT, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY CLINICAL DIAGNOSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY CLINICAL DIAGNOSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY CENTRAL LAB, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY CENTRAL LAB, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY POINT OF CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY POINT OF CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY CLINICAL DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY EPIDEMIOLOGICAL SURVEILLANCE, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY EPIDEMIOLOGICAL SURVEILLANCE, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY CONTACT TRACING STUDIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY CONTACT TRACING STUDIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SEROPREVALENCE SURVEYS, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SEROPREVALENCE SURVEYS, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY EPIDEMIOLOGICAL SURVEILLANCE, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY EPIDEMIOLOGICAL SURVEILLANCE, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY VACCINE DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY VACCINE DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY GOVERNMENT CONTRACTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY GOVERNMENT CONTRACTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY PRIVATE CONTRACTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY PRIVATE CONTRACTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY DIRECT SALES, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY DIRECT SALES, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY DISTRIBUTOR, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY DISTRIBUTOR, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY NATIONAL DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY NATIONAL DISTRIBUTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY REGIONAL DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY REGIONAL DISTRIBUTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY DISTRIBUTOR, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY DISTRIBUTOR, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY ONLINE SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY RAPID LATERAL FLOW, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY RAPID LATERAL FLOW, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY PRODUCT FORMAT, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY PRODUCT FORMAT, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY CLINICAL DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY EPIDEMIOLOGICAL SURVEILLANCE, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY EPIDEMIOLOGICAL SURVEILLANCE, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY DIRECT SALES, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY DIRECT SALES, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY DISTRIBUTOR, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY DISTRIBUTOR, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY RAPID LATERAL FLOW, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY RAPID LATERAL FLOW, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY PRODUCT FORMAT, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY PRODUCT FORMAT, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY CLINICAL DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY EPIDEMIOLOGICAL SURVEILLANCE, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY EPIDEMIOLOGICAL SURVEILLANCE, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY DIRECT SALES, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY DIRECT SALES, 2025-2030 (USD MILLION)
TABLE 147. UNITED STATES MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY DISTRIBUTOR, 2018-2024 (USD MILLION)
TABLE 148. UNITED STATES MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY DISTRIBUTOR, 2025-2030 (USD MILLION)
TABLE 149. UNITED STATES MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 150. UNITED STATES MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 151. CANADA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 152. CANADA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 153. CANADA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 154. CANADA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 155. CANADA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY RAPID LATERAL FLOW, 2018-2024 (USD MILLION)
TABLE 156. CANADA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY RAPID LATERAL FLOW, 2025-2030 (USD MILLION)
TABLE 157. CANADA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 158. CANADA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 159. CANADA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 160. CANADA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 161. CANADA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY PRODUCT FORMAT, 2018-2024 (USD MILLION)
TABLE 162. CANADA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY PRODUCT FORMAT, 2025-2030 (USD MILLION)
TABLE 163. CANADA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 164. CANADA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 165. CANADA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 166. CANADA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY CLINICAL DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 167. CANADA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY EPIDEMIOLOGICAL SURVEILLANCE, 2018-2024 (USD MILLION)
TABLE 168. CANADA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY EPIDEMIOLOGICAL SURVEILLANCE, 2025-2030 (USD MILLION)
TABLE 169. CANADA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 170. CANADA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 171. CANADA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY DIRECT SALES, 2018-2024 (USD MILLION)
TABLE 172. CANADA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY DIRECT SALES, 2025-2030 (USD MILLION)
TABLE 173. CANADA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY DISTRIBUTOR, 2018-2024 (USD MILLION)
TABLE 174. CANADA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY DISTRIBUTOR, 2025-2030 (USD MILLION)
TABLE 175. MEXICO MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 176. MEXICO MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 177. MEXICO MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 178. MEXICO MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 179. MEXICO MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY RAPID LATERAL FLOW, 2018-2024 (USD MILLION)
TABLE 180. MEXICO MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY RAPID LATERAL FLOW, 2025-2030 (USD MILLION)
TABLE 181. MEXICO MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 182. MEXICO MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 183. MEXICO MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 184. MEXICO MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 185. MEXICO MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY PRODUCT FORMAT, 2018-2024 (USD MILLION)
TABLE 186. MEXICO MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY PRODUCT FORMAT, 2025-2030 (USD MILLION)
TABLE 187. MEXICO MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 188. MEXICO MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 189. MEXICO MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 190. MEXICO MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY CLINICAL DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 191. MEXICO MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY EPIDEMIOLOGICAL SURVEILLANCE, 2018-2024 (USD MILLION)
TABLE 192. MEXICO MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY EPIDEMIOLOGICAL SURVEILLANCE, 2025-2030 (USD MILLION)
TABLE 193. MEXICO MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 194. MEXICO MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 195. MEXICO MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY DIRECT SALES, 2018-2024 (USD MILLION)
TABLE 196. MEXICO MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY DIRECT SALES, 2025-2030 (USD MILLION)
TABLE 197. MEXICO MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY DISTRIBUTOR, 2018-2024 (USD MILLION)
TABLE 198. MEXICO MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY DISTRIBUTOR, 2025-2030 (USD MILLION)
TABLE 199. BRAZIL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 200. BRAZIL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 201. BRAZIL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 202. BRAZIL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 203. BRAZIL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY RAPID LATERAL FLOW, 2018-2024 (USD MILLION)
TABLE 204. BRAZIL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY RAPID LATERAL FLOW, 2025-2030 (USD MILLION)
TABLE 205. BRAZIL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 206. BRAZIL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 207. BRAZIL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 208. BRAZIL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 209. BRAZIL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY PRODUCT FORMAT, 2018-2024 (USD MILLION)
TABLE 210. BRAZIL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY PRODUCT FORMAT, 2025-2030 (USD MILLION)
TABLE 211. BRAZIL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 212. BRAZIL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 213. BRAZIL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 214. BRAZIL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY CLINICAL DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 215. BRAZIL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY EPIDEMIOLOGICAL SURVEILLANCE, 2018-2024 (USD MILLION)
TABLE 216. BRAZIL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY EPIDEMIOLOGICAL SURVEILLANCE, 2025-2030 (USD MILLION)
TABLE 217. BRAZIL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 218. BRAZIL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 219. BRAZIL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY DIRECT SALES, 2018-2024 (USD MILLION)
TABLE 220. BRAZIL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY DIRECT SALES, 2025-2030 (USD MILLION)
TABLE 221. BRAZIL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY DISTRIBUTOR, 2018-2024 (USD MILLION)
TABLE 222. BRAZIL MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY DISTRIBUTOR, 2025-2030 (USD MILLION)
TABLE 223. ARGENTINA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 224. ARGENTINA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 225. ARGENTINA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 226. ARGENTINA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 227. ARGENTINA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY RAPID LATERAL FLOW, 2018-2024 (USD MILLION)
TABLE 228. ARGENTINA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY RAPID LATERAL FLOW, 2025-2030 (USD MILLION)
TABLE 229. ARGENTINA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 230. ARGENTINA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 231. ARGENTINA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 232. ARGENTINA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 233. ARGENTINA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY PRODUCT FORMAT, 2018-2024 (USD MILLION)
TABLE 234. ARGENTINA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY PRODUCT FORMAT, 2025-2030 (USD MILLION)
TABLE 235. ARGENTINA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 236. ARGENTINA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 237. ARGENTINA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 238. ARGENTINA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY CLINICAL DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 239. ARGENTINA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY EPIDEMIOLOGICAL SURVEILLANCE, 2018-2024 (USD MILLION)
TABLE 240. ARGENTINA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY EPIDEMIOLOGICAL SURVEILLANCE, 2025-2030 (USD MILLION)
TABLE 241. ARGENTINA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 242. ARGENTINA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 243. ARGENTINA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY DIRECT SALES, 2018-2024 (USD MILLION)
TABLE 244. ARGENTINA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY DIRECT SALES, 2025-2030 (USD MILLION)
TABLE 245. ARGENTINA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY DISTRIBUTOR, 2018-2024 (USD MILLION)
TABLE 246. ARGENTINA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY DISTRIBUTOR, 2025-2030 (USD MILLION)
TABLE 247. EUROPE, MIDDLE EAST & AFRICA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 248. EUROPE, MIDDLE EAST & AFRICA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 249. EUROPE, MIDDLE EAST & AFRICA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 250. EUROPE, MIDDLE EAST & AFRICA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 251. EUROPE, MIDDLE EAST & AFRICA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY RAPID LATERAL FLOW, 2018-2024 (USD MILLION)
TABLE 252. EUROPE, MIDDLE EAST & AFRICA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY RAPID LATERAL FLOW, 2025-2030 (USD MILLION)
TABLE 253. EUROPE, MIDDLE EAST & AFRICA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 254. EUROPE, MIDDLE EAST & AFRICA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 255. EUROPE, MIDDLE EAST & AFRICA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 256. EUROPE, MIDDLE EAST & AFRICA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 257. EUROPE, MIDDLE EAST & AFRICA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY PRODUCT FORMAT, 2018-2024 (USD MILLION)
TABLE 258. EUROPE, MIDDLE EAST & AFRICA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY PRODUCT FORMAT, 2025-2030 (USD MILLION)
TABLE 259. EUROPE, MIDDLE EAST & AFRICA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 260. EUROPE, MIDDLE EAST & AFRICA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 261. EUROPE, MIDDLE EAST & AFRICA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 262. EUROPE, MIDDLE EAST & AFRICA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY CLINICAL DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 263. EUROPE, MIDDLE EAST & AFRICA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY EPIDEMIOLOGICAL SURVEILLANCE, 2018-2024 (USD MILLION)
TABLE 264. EUROPE, MIDDLE EAST & AFRICA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY EPIDEMIOLOGICAL SURVEILLANCE, 2025-2030 (USD MILLION)
TABLE 265. EUROPE, MIDDLE EAST & AFRICA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 266. EUROPE, MIDDLE EAST & AFRICA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 267. EUROPE, MIDDLE EAST & AFRICA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY DIRECT SALES, 2018-2024 (USD MILLION)
TABLE 268. EUROPE, MIDDLE EAST & AFRICA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY DIRECT SALES, 2025-2030 (USD MILLION)
TABLE 269. EUROPE, MIDDLE EAST & AFRICA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY DISTRIBUTOR, 2018-2024 (USD MILLION)
TABLE 270. EUROPE, MIDDLE EAST & AFRICA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY DISTRIBUTOR, 2025-2030 (USD MILLION)
TABLE 271. EUROPE, MIDDLE EAST & AFRICA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 272. EUROPE, MIDDLE EAST & AFRICA MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 273. UNITED KINGDOM MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 274. UNITED KINGDOM MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 275. UNITED KINGDOM MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 276. UNITED KINGDOM MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 277. UNITED KINGDOM MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY RAPID LATERAL FLOW, 2018-2024 (USD MILLION)
TABLE 278. UNITED KINGDOM MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY RAPID LATERAL FLOW, 2025-2030 (USD MILLION)
TABLE 279. UNITED KINGDOM MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 280. UNITED KINGDOM MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 281. UNITED KINGDOM MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 282. UNITED KINGDOM MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 283. UNITED KINGDOM MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY PRODUCT FORMAT, 2018-2024 (USD MILLION)
TABLE 284. UNITED KINGDOM MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY PRODUCT FORMAT, 2025-2030 (USD MILLION)
TABLE 285. UNITED KINGDOM MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 286. UNITED KINGDOM MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 287. UNITED KINGDOM MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY CLINICAL DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 288. UNITED KINGDOM MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY CLINICAL DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 289. UNITED KINGDOM MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY EPIDEMIOLOGICAL SURVEILLANCE, 2018-2024 (USD MILLION)
TABLE 290. UNITED KINGDOM MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY EPIDEMIOLOGICAL SURVEILLANCE, 2025-2030 (USD MILLION)
TABLE 291. UNITED KINGDOM MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 292. UNITED KINGDOM MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 293. UNITED KINGDOM MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY DIRECT SALES, 2018-2024 (USD MILLION)
TABLE 294. UNITED KINGDOM MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY DIRECT SALES, 2025-2030 (USD MILLION)
TABLE 295. UNITED KINGDOM MONKEYPOX ANTIBODY TEST REAGENT MARKET SIZE, BY DISTRIBUTOR, 2018-

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Monkeypox Antibody Test Reagent market report include:
  • Thermo Fisher Scientific Inc.
  • Roche Diagnostics International AG
  • Abbott Laboratories
  • QIAGEN N.V.
  • PerkinElmer, Inc.
  • Bio-Rad Laboratories, Inc.
  • bioMérieux SA
  • DiaSorin S.p.A.
  • Bio-Techne Corporation
  • Virion\Serion GmbH

Related Topics

Related Reports

Monkeypox Antigen Test Reagent Market by Product Type (Analytical Instrument, Test Kit), Technology (Biosensor, Enzyme Linked Immunosorbent Assay, Lateral Flow Assay), End User, Test Type, Sample Type - Global Forecast 2025-2030 - Product Image

Monkeypox Antigen Test Reagent Market by Product Type (Analytical Instrument, Test Kit), Technology (Biosensor, Enzyme Linked Immunosorbent Assay, Lateral Flow Assay), End User, Test Type, Sample Type - Global Forecast 2025-2030

  • Report
  • 187 Pages
  • Global
From
Monkeypox Rapid Test Kit Market by Product Type (IgG, IgG/IgM Combined, IgM), Test Technology (Colloidal Gold Immunochromatographic Assay, Lateral Flow Immunoassay, Microfluidic Platform), End User, Distribution Channel - Global Forecast 2025-2030 - Product Image

Monkeypox Rapid Test Kit Market by Product Type (IgG, IgG/IgM Combined, IgM), Test Technology (Colloidal Gold Immunochromatographic Assay, Lateral Flow Immunoassay, Microfluidic Platform), End User, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 182 Pages
  • Global
From
Europe Monkeypox Testing Market - Industry Outlook and Forecast 2023-2025 - Product Image

Europe Monkeypox Testing Market - Industry Outlook and Forecast 2023-2025

  • Report
  • 159 Pages
  • Europe
From
U.S. Monkeypox Testing Market - Industry Outlook & Forecast 2023-2025 - Product Image

U.S. Monkeypox Testing Market - Industry Outlook & Forecast 2023-2025

  • Report
  • 165 Pages
  • United States
From
Global Monkeypox Diagnostics Market by Assay, Country, Product, and Place, with Executive & Consultant Guides and Market Analysis & Forecasts 2022-2026 - Product Image

Global Monkeypox Diagnostics Market by Assay, Country, Product, and Place, with Executive & Consultant Guides and Market Analysis & Forecasts 2022-2026

  • Report
  • 294 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.